Contrast induced nephropathy epidemiology and demographics
|
Contrast Induced Nephropathy Microchapters |
|
Differentiating Contrast induced nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Contrast induced nephropathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Contrast induced nephropathy epidemiology and demographics |
|
FDA on Contrast induced nephropathy epidemiology and demographics |
|
CDC on Contrast induced nephropathy epidemiology and demographics |
|
Contrast induced nephropathy epidemiology and demographics in the news |
|
Blogs on Contrast induced nephropathy epidemiology and demographics |
|
Directions to Hospitals Treating Contrast induced nephropathy |
|
Risk calculators and risk factors for Contrast induced nephropathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Incidence of CIN in the general population have been reported to be 0.6–2.3%.[1] Considered to be the third most common cause of renal failure with overall mortality rate 19.4%, which is similar for all causes of renal insufficiency.[2]
Epidemiology and Demographics
Decline in renal function remains a common event despite the improvement in the care of hospitalized patients, the incidence rate of contrast-induced nephropathy as a complication of radiographic diagnostic and interventional studies varies markedly depending on the definition used, and on other variables such as the type of radiology procedure performed, the dose and type of contrast agent administered, the different patient populations in regard to number and type of risk factors, and the length of patient follow-up.
Incidence varies in many studies according to the definition used, it is found to be 14.5% in a large epidemiological study[3], in which CIN defined as > 25% increase in serum creatinine levels over baseline in the first 5 days, Rates may vary depending on the presence of risk factors, patients with diabetes has been reported to be 9–40% in patients with mild-to-moderate chronic renal insufficiency, and 50–90% in those with severe chronic renal insufficiency.[4] [5] An overall incidence of CIN in the general population is reported to be 0.6–2.3%.[1] The overall mortality rate was 19.4% and was similar among patients for all causes of renal insufficiency, except sepsis. [2]
References
- ↑ 1.0 1.1 Lasser EC, Lyon SG, Berry CC (1997). "Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration". Radiology. 203 (3): 605–10. PMID 9169676.
- ↑ 2.0 2.1 Nash K, Hafeez A, Hou S (2002). "Hospital-acquired renal insufficiency". Am J Kidney Dis. 39 (5): 930–6. doi:10.1053/ajkd.2002.32766. PMID 11979336.
- ↑ McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW (1997). "Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality". Am J Med. 103 (5): 368–75. PMID 9375704.
- ↑ Harkonen S, Kjellstrand CM (1977). "Exacerbation of diabetic renal failure following intravenous pyelography". Am J Med. 63 (6): 939–46. PMID 605916.
- ↑ Manske CL, Sprafka JM, Strony JT, Wang Y (1990). "Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography". Am J Med. 89 (5): 615–20. PMID 2239981.